Vanguard Group
KZR icon

Vanguard Group’s Kezar Life Sciences KZR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.27M Hold
276,228
﹤0.01% 3675
2025
Q1
$1.35M Buy
276,228
+2,117
+0.8% +$10.3K ﹤0.01% 3621
2024
Q4
$1.84M Sell
274,111
-2,466,994
-90% -$16.6M ﹤0.01% 3584
2024
Q3
$2.12M Hold
2,741,105
﹤0.01% 3543
2024
Q2
$1.64M Sell
2,741,105
-353,119
-11% -$212K ﹤0.01% 3623
2024
Q1
$2.79M Buy
3,094,224
+30,740
+1% +$27.7K ﹤0.01% 3493
2023
Q4
$2.9M Buy
3,063,484
+22,917
+0.8% +$21.7K ﹤0.01% 3466
2023
Q3
$3.62M Buy
3,040,567
+7,497
+0.2% +$8.92K ﹤0.01% 3381
2023
Q2
$7.43M Buy
3,033,070
+20,954
+0.7% +$51.3K ﹤0.01% 3117
2023
Q1
$9.43M Sell
3,012,116
-13,867
-0.5% -$43.4K ﹤0.01% 2965
2022
Q4
$21.3M Buy
3,025,983
+32,776
+1% +$231K ﹤0.01% 2595
2022
Q3
$25.8M Buy
2,993,207
+556,020
+23% +$4.79M ﹤0.01% 2523
2022
Q2
$20.2M Buy
2,437,187
+209,103
+9% +$1.73M ﹤0.01% 2639
2022
Q1
$37M Buy
2,228,084
+336,669
+18% +$5.6M ﹤0.01% 2449
2021
Q4
$31.6M Sell
1,891,415
-25,434
-1% -$425K ﹤0.01% 2609
2021
Q3
$16.6M Buy
1,916,849
+12,056
+0.6% +$104K ﹤0.01% 2962
2021
Q2
$10.3M Buy
1,904,793
+39,271
+2% +$213K ﹤0.01% 3181
2021
Q1
$11.1M Buy
1,865,522
+58,684
+3% +$350K ﹤0.01% 3094
2020
Q4
$9.43M Buy
1,806,838
+242,345
+15% +$1.26M ﹤0.01% 3028
2020
Q3
$7.57M Buy
1,564,493
+11,976
+0.8% +$58K ﹤0.01% 2933
2020
Q2
$8.04M Buy
1,552,517
+281,447
+22% +$1.46M ﹤0.01% 2873
2020
Q1
$5.54M Buy
1,271,070
+915,169
+257% +$3.99M ﹤0.01% 2931
2019
Q4
$1.43M Sell
355,901
-16,327
-4% -$65.5K ﹤0.01% 3540
2019
Q3
$1.22M Sell
372,228
-28,357
-7% -$93K ﹤0.01% 3594
2019
Q2
$3.09M Sell
400,585
-5,398
-1% -$41.6K ﹤0.01% 3335
2019
Q1
$7.2M Buy
405,983
+235,627
+138% +$4.18M ﹤0.01% 2992
2018
Q4
$4.02M Buy
170,356
+137,792
+423% +$3.25M ﹤0.01% 3159
2018
Q3
$698K Sell
32,564
-7,436
-19% -$159K ﹤0.01% 3795
2018
Q2
$692K Buy
+40,000
New +$692K ﹤0.01% 3775